229 related articles for article (PubMed ID: 22916173)
1. Developmental alterations in motor coordination and medium spiny neuron markers in mice lacking pgc-1α.
Lucas EK; Dougherty SE; McMeekin LJ; Trinh AT; Reid CS; Cowell RM
PLoS One; 2012; 7(8):e42878. PubMed ID: 22916173
[TBL] [Abstract][Full Text] [Related]
2. Cell-Specific Deletion of PGC-1α from Medium Spiny Neurons Causes Transcriptional Alterations and Age-Related Motor Impairment.
McMeekin LJ; Li Y; Fox SN; Rowe GC; Crossman DK; Day JJ; Li Y; Detloff PJ; Cowell RM
J Neurosci; 2018 Mar; 38(13):3273-3286. PubMed ID: 29491012
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration.
Cui L; Jeong H; Borovecki F; Parkhurst CN; Tanese N; Krainc D
Cell; 2006 Oct; 127(1):59-69. PubMed ID: 17018277
[TBL] [Abstract][Full Text] [Related]
4. Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation.
Chaturvedi RK; Calingasan NY; Yang L; Hennessey T; Johri A; Beal MF
Hum Mol Genet; 2010 Aug; 19(16):3190-205. PubMed ID: 20529956
[TBL] [Abstract][Full Text] [Related]
5. Transducer of regulated CREB-binding proteins (TORCs) transcription and function is impaired in Huntington's disease.
Chaturvedi RK; Hennessey T; Johri A; Tiwari SK; Mishra D; Agarwal S; Kim YS; Beal MF
Hum Mol Genet; 2012 Aug; 21(15):3474-88. PubMed ID: 22589249
[TBL] [Abstract][Full Text] [Related]
6. A Role for Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1α in Nucleus Accumbens Neuron Subtypes in Cocaine Action.
Chandra R; Engeln M; Francis TC; Konkalmatt P; Patel D; Lobo MK
Biol Psychiatry; 2017 Apr; 81(7):564-572. PubMed ID: 27939396
[TBL] [Abstract][Full Text] [Related]
7. Nicotinamide improves motor deficits and upregulates PGC-1α and BDNF gene expression in a mouse model of Huntington's disease.
Hathorn T; Snyder-Keller A; Messer A
Neurobiol Dis; 2011 Jan; 41(1):43-50. PubMed ID: 20736066
[TBL] [Abstract][Full Text] [Related]
8. Activating mitochondrial regulator PGC-1α expression by astrocytic NGF is a therapeutic strategy for Huntington's disease.
Chen LW; Horng LY; Wu CL; Sung HC; Wu RT
Neuropharmacology; 2012 Sep; 63(4):719-32. PubMed ID: 22633948
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol protects against peripheral deficits in a mouse model of Huntington's disease.
Ho DJ; Calingasan NY; Wille E; Dumont M; Beal MF
Exp Neurol; 2010 Sep; 225(1):74-84. PubMed ID: 20561979
[TBL] [Abstract][Full Text] [Related]
10. An increase in murine skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) mRNA in response to exercise is mediated by beta-adrenergic receptor activation.
Miura S; Kawanaka K; Kai Y; Tamura M; Goto M; Shiuchi T; Minokoshi Y; Ezaki O
Endocrinology; 2007 Jul; 148(7):3441-8. PubMed ID: 17446185
[TBL] [Abstract][Full Text] [Related]
11. Sustained expression of PGC-1α in the rat nigrostriatal system selectively impairs dopaminergic function.
Ciron C; Lengacher S; Dusonchet J; Aebischer P; Schneider BL
Hum Mol Genet; 2012 Apr; 21(8):1861-76. PubMed ID: 22246294
[TBL] [Abstract][Full Text] [Related]
12. Mice lacking the transcriptional coactivator PGC-1α exhibit alterations in inhibitory synaptic transmission in the motor cortex.
Dougherty SE; Bartley AF; Lucas EK; Hablitz JJ; Dobrunz LE; Cowell RM
Neuroscience; 2014 Jun; 271():137-48. PubMed ID: 24769433
[TBL] [Abstract][Full Text] [Related]
13. Mitogen- and stress-activated protein kinase 1-induced neuroprotection in Huntington's disease: role on chromatin remodeling at the PGC-1-alpha promoter.
Martin E; Betuing S; Pagès C; Cambon K; Auregan G; Deglon N; Roze E; Caboche J
Hum Mol Genet; 2011 Jun; 20(12):2422-34. PubMed ID: 21493629
[TBL] [Abstract][Full Text] [Related]
14. PGC-1α negatively regulates extrasynaptic NMDAR activity and excitotoxicity.
Puddifoot C; Martel MA; Soriano FX; Camacho A; Vidal-Puig A; Wyllie DJ; Hardingham GE
J Neurosci; 2012 May; 32(20):6995-7000. PubMed ID: 22593067
[TBL] [Abstract][Full Text] [Related]
15. The role of PGC-1α in the pathogenesis of neurodegenerative disorders.
Róna-Vörös K; Weydt P
Curr Drug Targets; 2010 Oct; 11(10):1262-9. PubMed ID: 20840068
[TBL] [Abstract][Full Text] [Related]
16. PGC-1alpha is not mandatory for exercise- and training-induced adaptive gene responses in mouse skeletal muscle.
Leick L; Wojtaszewski JF; Johansen ST; Kiilerich K; Comes G; Hellsten Y; Hidalgo J; Pilegaard H
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E463-74. PubMed ID: 18073319
[TBL] [Abstract][Full Text] [Related]
17. Real-time imaging of peroxisome proliferator-activated receptor-gamma coactivator-1alpha promoter activity in skeletal muscles of living mice.
Akimoto T; Sorg BS; Yan Z
Am J Physiol Cell Physiol; 2004 Sep; 287(3):C790-6. PubMed ID: 15151904
[TBL] [Abstract][Full Text] [Related]
18. PGC-1α at the intersection of bioenergetics regulation and neuron function: from Huntington's disease to Parkinson's disease and beyond.
Tsunemi T; La Spada AR
Prog Neurobiol; 2012 May; 97(2):142-51. PubMed ID: 22100502
[TBL] [Abstract][Full Text] [Related]
19. Neuronal inactivation of peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) protects mice from diet-induced obesity and leads to degenerative lesions.
Ma D; Li S; Lucas EK; Cowell RM; Lin JD
J Biol Chem; 2010 Dec; 285(50):39087-95. PubMed ID: 20947495
[TBL] [Abstract][Full Text] [Related]
20. Parvalbumin deficiency and GABAergic dysfunction in mice lacking PGC-1alpha.
Lucas EK; Markwardt SJ; Gupta S; Meador-Woodruff JH; Lin JD; Overstreet-Wadiche L; Cowell RM
J Neurosci; 2010 May; 30(21):7227-35. PubMed ID: 20505089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
